HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.

Abstract
Heparin-induced thrombocytopenia (HIT) is due primarily to IgG antibodies specific to platelet factor 4/heparin complexes (PF4/Hs) that activate platelets via FcγRIIA. CD148 is a protein tyrosine phosphatase that regulates Src kinases and collagen-induced platelet activation. Three polymorphisms affecting CD148 (Q276P, R326Q, and D872E) were studied in HIT patients and 2 control groups, with or without antibodies to PF4/Hs. Heterozygote status for CD148 276P or 326Q alleles was less frequent in HIT patients, suggesting a protective effect of these polymorphisms. Aggregation tests performed with collagen, HIT plasma, and monoclonal antibodies cross-linking FcγRIIA showed consistent hyporesponsiveness of platelets expressing the 276P/326Q alleles. In addition, platelets expressing the 276P/326Q alleles exhibited a greater sensitivity to the Src family kinases inhibitor dasatinib in response to collagen or ALB6 cross-linking FcγRIIA receptors. Moreover, the activatory phosphorylation of Src family kinases was considerably delayed as well as the phosphorylation of Linker for activation of T cells and phospholipase Cγ2, 2 major signaling proteins downstream from FcγRIIA. In conclusion, this study shows that CD148 polymorphisms affect platelet activation and probably exert a protective effect on the risk of HIT in patients with antibodies to PF4/Hs.
AuthorsJérôme Rollin, Claire Pouplard, Marie-Pierre Gratacap, Dorothée Leroux, Marc-Antoine May, Michel Aupart, Valérie Gouilleux-Gruart, Bernard Payrastre, Yves Gruel
JournalBlood (Blood) Vol. 120 Issue 6 Pg. 1309-16 (Aug 09 2012) ISSN: 1528-0020 [Electronic] United States
PMID22677127 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FCGR2A protein, human
  • Receptors, IgG
  • Platelet Factor 4
  • Heparin
  • PTPRJ protein, human
  • Protein Tyrosine Phosphatases
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3
Topics
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Heparin (adverse effects, immunology, metabolism)
  • Humans
  • Male
  • Platelet Activation (genetics)
  • Platelet Factor 4 (immunology, metabolism)
  • Polymorphism, Single Nucleotide (physiology)
  • Protein Tyrosine Phosphatases (genetics)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3 (genetics, physiology)
  • Receptors, IgG (genetics, metabolism, physiology)
  • Risk Factors
  • Thrombocytopenia (blood, etiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: